Table 2 Onset of infection, organism, days of antibiotics used
Median time to infection Days | First Infection n = 67 [IQR] | Predominant Organisms | Antibiotic DOT Total, median, [IQR] | Second Infection n = 38 [IQR] | Predominant Organisms | Antibiotic DOT Total, median, [IQR] | Total | Mean total /Person | |
|---|---|---|---|---|---|---|---|---|---|
All infections 67 | 97.5 [37–365] | 2063; 16.5 [10–42] | All 38 | 158.5 [37–257] | 1897 37.5 [14-66.5] | 3960 | 59.1 | ||
Uncomplicated percutaneous lead (PL) ( i.e. superficial PL) 31 | 142 [40–404] | No CX: 16 MSSA 9/15 CoNS 3/15 Coryn 2/15 All others 1/15 each* | 932 10 [8.5–28.5] | Superficial 20 | 68.5 [32–224] | No Culture 6 MSSA 3/14 MRSA 2/14 Coryn. 1 Staph sp. 1 Strep 1 Gram negs 4 | 1031 17 [10–60] | ||
Complicated percutaneous lead (deep PL, excluding bloodstream infection) 4 | 200 [142–390] | No growth 1/4 Poly-microbial 2/4 P. aeruginosa 3/4 | 227 79 [27-160.5] | Deep 3 | 156 [171–206] | S. epidermatus S. pyogenese P. aeruginosa Coryne MSSA | 72 47.2 mean | ||
Bloodstream infection 24 | 64 [41–434] | Streptococcal spp. 5/24 CoNS 4/24 E. fecalis 3/24 MSSA 2/24 MRSA 2/24 K. pneumonia 2/24 All others** 1/24 | 737 30 [15–51] | Blood contacting surface 7 | 214 [56–303] | C. glabrata 2 Weisella confusa 1 P. aeruginosa 1 MRSA 1 E. coli MSSA | 627 49 [19–100] | ||
Surgical site infection 8 | 15.5 [9.5–46.5] | No CX 2 No growth 1/6 All other*** 1/6 | 167 14 [11.5–46] | SSI 2 | 174 [39-648.5] | No cultures 2/2 | 167 71 [14–83] |